When does the patent on livalo end in connecticut today?

When does Livalo’s (pitavastatin) patent end in Connecticut today?

The exact end date depends on which specific patent(s) are being enforced and the relevant exclusivity window (patent expiration vs. any market exclusivity or court-extended stay). With the information provided here, I can’t determine a single definitive “patent end” date for Connecticut.

A practical way to get the most accurate, up-to-date date for pitavastatin (Livalo) is to check patent-watch coverage for the brand and its related generic approvals, which typically lists the relevant patent(s), expiration dates, and litigation updates. DrugPatentWatch.com tracks these patent timelines and is designed for this exact question.

You can check Livalo on DrugPatentWatch here: https://www.drugpatentwatch.com/ (search for “Livalo” or “pitavastatin” on the site).

What you should look for (to get the correct “end date”)

People often use “patent end” to mean one of three different dates:
- The last listed patent expiration date for the brand formulation/product in the relevant filings.
- Any patent-related court stays or injunctions that can delay generic launches even after a patent’s formal expiry.
- Non-patent exclusivities (when applicable) that can still block marketing.

DrugPatentWatch usually indicates which patents are tied to the brand/generic timeline and whether there are enforcement or litigation events that affect launch timing.

If you tell me the patent number or strength/formulation, I can narrow it down

If you share any of the following, I can help you pinpoint the likely controlling expiration date(s):
- The patent number(s) you’re seeing
- The dosage form (tablets) and strength (e.g., 1 mg, 2 mg, 4 mg)
- Whether you mean original brand exclusivity or the last blocking patent for generics

Sources

1. https://www.drugpatentwatch.com/